Background The alveolar macrophage is believed to be important in the defence of the lung and possibly in the pathogenesis of lung disease. Cell counts in bronchoalveolar lavage fluid have suggested that smokers have an increased number of alveolar macrophages but have not enabled the number to be related to a measure of lung
The alveolar macrophage is important in the defence of the lung from external factors such as microbes, dust, and other foreign material.' Its phagocytic capabilities provide the first line of defence against these agents in the distal lung and its importance is illustrated by the clinical sequelae observed in patients with abnormal phagocyte function.2 In more recent years it has been shown that as well as having a defensive role in the lung the alveolar macrophage may be important in the pathogenesis of pulmonary disease. 3 Release of enzymes and chemical mediators from alveolar macrophages may result in pulmonary fibrosis,4 and some believe that the alveolar macrophage may have an important role in the pathogenesis of emphysema. 5 If the alveolar macrophage plays a part either actively or protectively in pulmonary disease it is relevant to assess their number in a quantitative manner. Studies of alveolar macrophage numbers in bronchoalveolar lavage fluid have shown a greater number in smokers than in non-smokers, ' In this paper we have studied the alveolar macrophage number in relation to unit lung volume and unit surface area in a group of smokers and non-smokers.
Methods

PATIENTS
Surgical resection specimens were obtained from patients undergoing pulmonary surgery for small peripheral lesions at the City Hospital, Edinburgh. Smoking histories were obtained by questionnaire: twelve patientsseven of them men-said that they were current smokers (age 46-66, mean 59-2 years) and nine-six of them men-that they were non-smokers (age 21-69, mean 52-6 years); these included two who had given up smoking more than six months before. All patients had to be fit for a thoracotomy, so patients with severe emphysema were excluded.
The specimens were carefully selected, all having peripheral lesions and no evidence of proximal bronchial obstruction. The specimens from smokers consisted of four pneumonectomy and eight lobectomy specimens. Eleven patients had small peripheral bronchial carcinomas and one had a small, localised area of resolving aspiration pneumonia. The specimens from non-smokers consisted of one pneumonectomy and eight lobectomy specimens (two bronchial carcinomas, two pulmonary carcinoid tumours, and one localised area of scarring thought on clinical grounds to be a peripheral tumour).
The specimens were transferred within two hours to the laboratory, where they were inflated and fixed transbronchially at 25 cm pressure with 10% formol saline. After 24 hours the lungs were serially sliced at 1 cm intervals in the parasagittal plane. After removal of diagnostic material six random 2 x 2 cm blocks were taken, the segment containing the lesion being avoided. None of the blocks showed any evidence of the lesion or of any pathological process resulting from it. The tissue was processed and embedded in glycol methacrylate resin. The blocks were cut into 3 im sections and stained with haematoxylin and eosin. One further block was taken for processing in paraffin wax.
MEASUREMENT OF LUNG ARCHITECTURE
Airspace wall surface area per unit volume (AWUV) was measured on the histological sections of lung tissue with an automated scanner, the fast interval processor.'5 This is an automated device for measuring the mean distance between alveolar walls, expressed as the mean linear intercept (Lm). This figure (Lm) can be used to calculate surface area by using the formula'6 Figure 1 illustrates the results of the measurements of lung structure in each of the 12 current smokers and nine non-smokers. The mean measured AWUV value (mm2/mm3) was significantly lower (p < 0-05) for the current smokers (15-35 (0-91) We believe that if further data on the protective or pathogenetic roles of the alveolar macrophage are to be assessed meaningfully they must be quantitatively related to lung tissue. Expressing the number per unit lung volume or unit surface area provides a natural way of expressing the cell numbers in the context of variable abnormal lung architecture, something that previously has not been possible. This approach may be of value in the study of other inflammatory cells in the pulmonary parenchyma.
